Discover, Validate and Productize novel biomarkers, diagnostics & clinical algorithms with life-saving potential. Our advanced AI and machine learning algorithms, combined with our expertise in assay development, imaging, and regulatory compliance, enable companies to develop and launch their tests faster and more effectively.
Sonrai For Diagnostics
Sonrai Discovery empowers diagnostic companies to fully utilize the valuable information obtained from your projects and bring together insights from various aspects of your research. Our breakthrough technology can revolutionize clinical pathways and add immense value to your research and discovery projects.
No matter where you are on your journey, Sonrai can help. Click the buttons below for more information on how we enhance .
Sonrai Discovery integrates clinical, molecular, multi-omics, and imaging data using AI to identify novel disease biomarkers for diagnostic tests. We maximize the performance of your biomarkers by generating insights from your data, incorporating public data and helping you develop your existing markers into effective tests.
Discovery
Our end-to-end data solution is streamlined to support your analysts with advanced AI and Machine Learning tools, reducing time-to-discovery by up to 50% and cutting the high costs of biomarker validation.
Our technology enables users of all backgrounds to quickly and easily build new data pipelines and workflows and to seamlessly run thousands of experiments across hundreds of use cases.
Sonrai treats your data like code by generating automatic track and trace recording, data lineage, and versions, allowing you to experiment in a secure research environment. This functionality allows you to roll back to previous versions quickly and efficiently.
Maximize the potential of your imaging and omic data in discovering and analyzing diverse biomarkers across various modalities. This data integration allows you to utilize the valuable information obtained from your projects fully. It brings together insights from multiple aspects of medical research, including pathology images, gene expression, protein expression and other molecular data.
Sonrai helps you identify suitable candidate biomarkers, establish robust assays with appropriate controls, and assign experienced project managers to ensure your project is completed on time and to the highest standards. We also offer algorithm co-development services to optimize diagnostic tests and reduce costs. Let's work together to develop effective diagnostic tests that improve patient outcomes.
Development
Our biomarker experts help you create robust study designs for biomarker validation for greater confidence in the resultant data. Sonrai incorporates AI and ML applications to refine gene signatures - which are crucial for detecting diseases at an early stage. We can improve the accuracy of your diagnostic tests and make them more effective in detecting diseases.
We work closely with our clients to select the most effective and efficient methods for delivering test results to patients or healthcare providers. Sonrai ensures that diagnostic tests are designed and optimized to be reliable and accurate by selecting appropriate controls and reference genes to ensure that test results are reproducible and consistent.
Biomarker Test Delivery
Dedicated Project Management
Co-Develop Algorithms
Achieve greater confidence in your resultant data through our biomarker validation services. Our biomarker experts work with you to create robust study designs, define appropriate analytical validation studies, and design optimal clinical validation studies for your diagnostic tests. With our expert regulatory support, including our in-house regulatory team for IVDR, FDA, and CLIA, you can easily navigate regulatory requirements.
Validation
At Sonrai, we specialize in developing accurate and reliable diagnostic tests that meet IVDR, FDA, and CLIA regulatory requirements. Our AI biomarker discovery technology and diagnostic tests are designed to ensure compliance with regulatory guidelines, while our clinical performance studies provide accurate and reliable data.
Whether you need support for validation studies or assay development services, our expert team is here to help. We offer expert biomarker validation study design and expertise in image analysis using AI to provide more precise diagnoses. Contact us to learn more about our biomarker validation services and how we can help you develop innovative diagnostic solutions that improve patient outcomes.
Deploy a variety of data products, including bioinformatics analysis, digital assays, and machine learning models or build imaging algorithms, using a data mesh architecture. Utilize cloud technology and best-practice MLOps to train, deploy, and manage AI algorithms. Foster sharing and collaboration with colleagues and key stakeholders to promote the advancement of biomarker potential.
With our expert team and cutting-edge technology, we help you deploy clinical grade AI algorithms for image and data analysis.
Join forces with us to create clinical-grade AI models that can accurately identify features in images and quantify biomarkers. These models can be used to store, retrieve, and analyze large amounts of data, making your research and analysis more efficient and effective for your medical device development.
We aim for perfection for our clients. We listen to their goals, quickly grasp their challenges, consider the needs of all stakeholders and deliver technical solutions. Below are just some of our client case studies to view.
PDL-1 AI Algorithm
Challenge
The current manual process of PD-L1 scoring by pathologists is time-consuming and challenging.
How We Helped
Sonrai is implementing an AI algorithm to assist pathologists, simplify the process with potential savings for the NHS of up to £3.2m each year. reduce the cost of the pathologists and patient time.
AI MSI Status Prediction
Challenge
For a more efficient and accurate method to identify patients who require further testing for Lynch Syndrome.
How We Helped
We're creating a clinical app to predict MSI status from H&E-stained slides of colorectal cancer, augmenting wet-lab identification of Lynch Syndrome patients for further testing.
